Given the increasing problems posed by antibiotic resistance, there is keen interest in alternative strategies. Here, James Paton and colleagues review recent progress made in one such alternative strategy — creating recombinant receptor-mimic probiotics for the treatment and prevention of enteric infections.
- Adrienne W. Paton
- Renato Morona
- James C. Paton
